31189856|t|[Retrospective Observational Study on Chemical Coping].
31189856|a|Chemical coping also has an idea that it is an early stage of abuse and dependence of opioids, it is important to grasp the frequency, complaints, and risk factors of chemical coping. In this study, observational research was performed backwardly with 549 people using opioids who were newly requested to the palliative care team. Results revealed that 13 of 549 patients (2.4%)were diagnosed with chemical coping. In terms of a breakdown of the complaint, and it was following rate and reasons, 6 people(46%)felt easy, 2 people(15%)were anxious, 2 people(15%)could sleep, 2 people(15%)had unknown reasons, and 1(8%)was calm. Characteristics of each patient diagnosed with chemical coping included frequent psychiatric symptoms such as life expectancy of 3 months, opioid oral administration period of 1 year or more, disease incidence period of 1 year or more, anxiety, delirium, and depression. One benign disease also confirmed the transition to opioid dependence.
31189856	118	123	abuse	Disease	MESH:D019966
31189856	312	318	people	Species	9606
31189856	419	427	patients	Species	9606
31189856	554	560	people	Species	9606
31189856	578	584	people	Species	9606
31189856	594	601	anxious	Disease	
31189856	605	611	people	Species	9606
31189856	631	637	people	Species	9606
31189856	706	713	patient	Species	9606
31189856	763	774	psychiatric	Disease	MESH:D001523
31189856	918	925	anxiety	Disease	MESH:D001007
31189856	927	935	delirium	Disease	MESH:D003693
31189856	941	951	depression	Disease	MESH:D003866
31189856	1005	1022	opioid dependence	Disease	MESH:D009293

